RLAY Relay Therapeutics, Inc.
Relay Therapeutics, Inc. (RLAY) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 8% planned / 92% discretionary
Largest single sale: $116.4M.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Patel Sanjiv | President and CEO | Sell 10b5-1 | 48,199 | $18.94 | $912.9K | 519,500 −8.5% of holding | |
| Catinazzo Thomas | Chief Financial Officer | Sell 10b5-1 | 17,717 | $18.94 | $335.6K | 122,851 −12.6% of holding | |
| Bergstrom Donald A | President, R&D | Sell 10b5-1 | 8,530 | $18.97 | $161.8K | 399,130 −2.1% of holding | |
| Rahmer Peter | See remarks | Sell 10b5-1 | 4,508 | $20.03 | $90.3K | 223,657 −2% of holding | |
| Sell | 6,000,000 | $19.40 | $116.4M | 21,904,963 −21.5% of holding | |||
| Patel Sanjiv | President and CEO | Sell 10b5-1 | 48,199 | $20.33 | $979.9K | 567,699 −7.8% of holding | |
| Catinazzo Thomas | Chief Financial Officer | Sell 10b5-1 | 17,717 | $19.74 | $349.7K | 140,568 −11.2% of holding | |
| Bergstrom Donald A | President, R&D | Sell | 2,237 | $18.61 | $41.6K | 407,660 −0.5% of holding | |
| Catinazzo Thomas | Chief Financial Officer | Sell | 1,459 | $18.61 | $27.2K | 158,285 −0.9% of holding | |
| Rahmer Peter | See remarks | Sell | 748 | $18.61 | $13.9K | 228,165 −0.3% of holding | |
| Patel Sanjiv | President and CEO | Sell 10b5-1 | 48,199 | $19.58 | $943.7K | 615,898 −7.3% of holding | |
| Catinazzo Thomas | Chief Financial Officer | Sell 10b5-1 | 17,717 | $18.69 | $331.1K | 159,744 −10% of holding | |
| Bergstrom Donald A | President, R&D | Sell 10b5-1 | 8,660 | $18.71 | $162.0K | 409,897 −2.1% of holding | |
| Rahmer Peter | See remarks | Sell 10b5-1 | 50,000 | $19.09 | $954.5K | 225,857 −18.1% of holding | |
| Catinazzo Thomas 4 fills | Chief Financial Officer | Sell 10b5-1 | 187,163 | $16.97 | $3.2M | 177,461 −51.3% of holding | |
| Bergstrom Donald A | President, R&D | Sell 10b5-1 | 93,456 | $16.94 | $1.6M | 418,557 −18.3% of holding | |
| Catinazzo Thomas | Chief Financial Officer | Sell 10b5-1 | 17,717 | $12.86 | $227.8K | 195,178 −8.3% of holding | |
| Bergstrom Donald A | President, R&D | Sell | 1,490 | $14.79 | $22.0K | 418,557 −0.4% of holding | |
| Catinazzo Thomas | Chief Financial Officer | Sell | 972 | $14.79 | $14.4K | 212,895 −0.5% of holding | |
| Rahmer Peter | See remarks | Sell | 753 | $14.79 | $11.1K | 275,857 −0.3% of holding | |
| Catinazzo Thomas | Chief Financial Officer | Sell 10b5-1 | 1,800 | $15.00 | $27.0K | 213,867 −0.8% of holding | |
| Catinazzo Thomas | Chief Financial Officer | Sell 10b5-1 | 17,717 | $13.01 | $230.5K | 213,867 −7.7% of holding | |
| Catinazzo Thomas | Chief Financial Officer | Sell 10b5-1 | 17,717 | $10.06 | $178.2K | 231,584 −7.1% of holding | |
| Bergstrom Donald A | President, R&D | Sell | 2,686 | $8.45 | $22.7K | 420,047 −0.6% of holding | |
| Catinazzo Thomas | Chief Financial Officer | Sell | 1,695 | $8.45 | $14.3K | 249,301 −0.7% of holding | |
| Rahmer Peter | See remarks | Sell | 1,354 | $8.45 | $11.4K | 276,610 −0.5% of holding | |
| Bergstrom Donald A | President, R&D | Sell | 18,895 | $7.62 | $144.0K | 422,733 −4.3% of holding | |
| Catinazzo Thomas | Chief Financial Officer | Sell | 13,820 | $7.62 | $105.3K | 250,996 −5.2% of holding | |
| Rahmer Peter | See remarks | Sell | 11,684 | $7.62 | $89.0K | 277,964 −4% of holding | |
| Patel Sanjiv | President and CEO | Sell | 43,168 | $7.82 | $337.6K | 661,041 −6.1% of holding | |
| Patel Sanjiv | President and CEO | Sell | 62,073 | $7.00 | $434.5K | 703,215 −8.1% of holding | |
| Rahmer Peter | See remarks | Sell | 21,394 | $7.50 | $160.5K | 337,469 −6% of holding | |
| Bergstrom Donald A | President, R&D | Sell | 30,897 | $7.29 | $225.2K | 521,823 −5.6% of holding | |
| Catinazzo Thomas | Chief Financial Officer | Sell | 21,664 | $7.29 | $157.9K | 313,631 −6.5% of holding | |
| Rahmer Peter | See remarks | Sell | 19,135 | $7.29 | $139.5K | 358,863 −5.1% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.